Collagen Cross-Linking: Current Status and Future Directions
Open Access
- 12 January 2012
- journal article
- review article
- Published by Hindawi Limited in Journal of Ophthalmology
- Vol. 2012, 1-12
- https://doi.org/10.1155/2012/406850
Abstract
Collagen cross-linking (CXL) using UVA light and riboflavin (vitamin B2) was introduced as a clinical application to stabilize the cornea by inducing cross-links within and between collagen fibers. CXL has been investigated extensively and has been shown clinically to arrest the progression of keratoconic or post-LASIK ectasia. With its minimal cost, simplicity, and proven positive clinical outcome, CXL can be regarded as a useful approach to reduce the number of penetrating keratoplasties performed. Small case series have also indicated that CXL is beneficial in corneal edema by reducing stromal swelling behavior and in keratitis by inhibiting pathogen growth. Despite these encouraging results, CXL remains a relatively new method that is potentially associated with complications. Aspects such as side effects and recurrence rates have still to be elucidated. In light of the growing interest in CXL, our paper summarizes present knowledge about this promising approach. We have intentionally endeavored to include the more relevant studies from the recent literature to provide an overview of the current status of CXL.Keywords
This publication has 124 references indexed in Scilit:
- π-Electron Currents in Polycyclic Conjugated Hydrocarbons of Decreasing Aromatic Character and a Novel Structural Definition of Aromaticity#The Open Ophthalmology Journal, 2011
- Immunofluorescence of Rabbit Corneas After Collagen Cross-Linking Treatment With Riboflavin and Ultraviolet ACornea, 2010
- Effects of Multicurve RGP Contact Lens Use on Topographic Changes in KeratoconusKorean Journal of Ophthalmology, 2010
- Mechanisms of Corneal Tissue Cross-linking in Response to Treatment with Topical Riboflavin and Long-Wavelength Ultraviolet Radiation (UVA)Investigative Opthalmology & Visual Science, 2010
- Endothelial Cell Density to Predict Endothelial Graft Failure After Penetrating KeratoplastyAmerican Journal of Ophthalmology, 2010
- Customized pachymetric guided epithelial debridement for corneal collagen cross linkingBMC Ophthalmology, 2009
- Antimicrobial Efficacy of Riboflavin/UVA Combination (365 nm) In Vitro for Bacterial and Fungal Isolates: A Potential New Treatment for Infectious KeratitisInvestigative Opthalmology & Visual Science, 2008
- Corneal Healing After Riboflavin Ultraviolet-A Collagen Cross-Linking Determined by Confocal Laser Scanning Microscopy In Vivo: Early and Late ModificationsAmerican Journal of Ophthalmology, 2008
- Ultraviolet A/Riboflavin Corneal Cross-linking for Infectious Keratitis Associated With Corneal MeltsCornea, 2008
- Increased resistance of crosslinked cornea against enzymatic digestionCurrent Eye Research, 2004